Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays (original) (raw)

Nature Biotechnology volume 18, pages 1001–1005 (2000)Cite this article

Abstract

Human cancers arise by a combination of discrete mutations and chromosomal alterations. Loss of heterozygosity (LOH) of chromosomal regions bearing mutated tumor suppressor genes is a key event in the evolution of epithelial and mesenchymal tumors1. Global patterns of LOH can be understood through allelotyping of tumors with polymorphic genetic markers2. Simple sequence length polymorphisms (SSLPs, or microsatellites) are reliable genetic markers for studying LOH3, but only a modest number of SSLPs are used in LOH studies because the genotyping procedure is rather tedious. Here, we report the use of a highly parallel approach to genotype large numbers of single-nucleotide polymorphisms (SNPs) for LOH, in which samples are genotyped for nearly 1,500 loci by performing 24 polymerase chain reactions (PCR), pooling the resulting amplification products and hybridizing the mixture to a high-density oligonucleotide array4. We characterize the results of LOH analyses on human small-cell lung cancer (SCLC) and control DNA samples by hybridization. We show that the patterns of LOH are consistent with those obtained by analysis with both SSLPs5 and comparative genomic hybridization (CGH), whereas amplifications rarely are detected by the SNP array. The results validate the use of SNP array hybridization for tumor studies.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Weinberg, R.A. Tumor suppressor genes. Science 254, 1138–1146 (1991).
    Article CAS Google Scholar
  2. Vogelstein, B. et al. Allelotype of colorectal carcinomas. Science 244, 207–211 (1989).
    Article CAS Google Scholar
  3. Weissenbach, J. et al. A second-generation linkage map of the human genome. Nature 359, 794–801 (1992).
    Article CAS Google Scholar
  4. Wang, D.G. et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077–1082 (1998).
    Article CAS Google Scholar
  5. Stanton, S.E., Shin, S.W., Johnson, B.E. & Meyerson, M. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosom. Cancer 27, 323–331 (2000).
    Article CAS Google Scholar
  6. Lindblad-Toh, K. et al. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat. Genet. 24, 381–386 (2000).
    Article CAS Google Scholar
  7. Hahn, S.A. et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55, 4670–4675 (1995).
    CAS Google Scholar
  8. Whang-Peng, J. et al. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet. Cytogenet. 6, 119–134 (1982).
    Article CAS Google Scholar
  9. Naylor, S.L., Johnson, B.E., Minna, J.D. & Sakaguchi, A.Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329, 451–454 (1987).
    Article CAS Google Scholar
  10. Johnson, B.E. et al. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res. 48, 5163–5166 (1988).
    CAS PubMed Google Scholar
  11. Ried, T. et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54, 1801–1806 (1994).
    CAS PubMed Google Scholar
  12. Levin, N.A., Brzoska, P.M., Warnock, M.L., Gray, J.W. & Christman, M.F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosom. Cancer 13, 175–185 (1995).
    Article CAS Google Scholar
  13. Petersen, I. et al. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br. J. Cancer 75, 79–86 (1997).
    Article CAS Google Scholar
  14. Farnebo, F. et al. Alternative genetic pathways in parathyroid tumorigenesis. J. Clin. Endocrinol. Metab. 84, 3775–3780 (1999).
    CAS PubMed Google Scholar
  15. Stanford Human Genome Center RH Server. http://www.shgc.stanford.edu/RH/index.html
  16. Walter, M., Spillett, D., Thomas, P., Weissenbach, J. & Goodfellow, P. A method for constructing radiation hybrid maps of whole genomes. Nat. Genet. 7, 22–28 (1994).
    Article CAS Google Scholar
  17. RHmapper. http://www.genome.wi.mit.edu/cgi-bin/contig/rhmapper.pl
  18. Brodeur, G.M., Williams, D.L., Look, A.T., Bowman, W.P. & Kalwinsky, D.K. Near-haploid acute lymphoblastic leukemia: a unique subgroup with a poor prognosis? Blood 58, 14–19 (1981).
    CAS PubMed Google Scholar
  19. SCLC-SNP-LOH site. http://www.genome.wi.mit.edu/SNP/human/LOH/

Download references

Acknowledgements

We thank T. Webster, N. Nouri, N. Patil, and T. Ryder at Affymetrix, Inc., for valuable assistance with the HuSNP chip. This research was supported in part by a research contract from Bristol-Myers Squibb, Millennium Pharmaceuticals, Inc., Affymetrix (E.S.L. and T.J.H.), and grants from the Pew Foundation (M.M.), the American Lung Association (M.M.), and the National Institutes of Health (HG01806). K.L. is the recipient of a scholarship from the Swedish Institute (4478/1998). D.M.T. is the recipient of a Harvard Medical School Pathology Fellowship (5T34CA72320-03). L.W.O and C.L. were supported by the Swedish Cancer Foundation and by the Torsten and Ragnar Söderberg Foundations. T.J.H. is a recipient of a clinician-scientist award from the Medical Research Council of Canada.

Author information

Author notes

  1. Kerstin Lindblad-Toh and David M. Tanenbaum: These two authors contributed equally to this work.

Authors and Affiliations

  1. Whitehead Institute/MIT Center for Genome Research, Whitehead Institute for Biomedical Research, Cambridge, 02139, MA
    Kerstin Lindblad-Toh, Mark J. Daly, Ellen Winchester, Anuradha Villapakkam, Thomas J. Hudson & Eric S. Lander
  2. Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA
    David M. Tanenbaum, Sasha E. Stanton, Bruce E. Johnson & Matthew Meyerson
  3. Department of Medicine, Harvard Medical School, Boston, MA
    David M. Tanenbaum & Bruce E. Johnson
  4. Department of Pathology, Harvard Medical School, Boston, MA
    David M. Tanenbaum & Matthew Meyerson
  5. Department of Molecular Medicine, CMM, Karolinska Hospital, Stockholm, S-171 76, Sweden
    Weng-Onn Lui & Catharina Larsson
  6. Montreal Genome Centre, McGill University Health Centre, Montréal, Québec
    Thomas J. Hudson
  7. Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, MA
    Eric S. Lander

Authors

  1. Kerstin Lindblad-Toh
    You can also search for this author inPubMed Google Scholar
  2. David M. Tanenbaum
    You can also search for this author inPubMed Google Scholar
  3. Mark J. Daly
    You can also search for this author inPubMed Google Scholar
  4. Ellen Winchester
    You can also search for this author inPubMed Google Scholar
  5. Weng-Onn Lui
    You can also search for this author inPubMed Google Scholar
  6. Anuradha Villapakkam
    You can also search for this author inPubMed Google Scholar
  7. Sasha E. Stanton
    You can also search for this author inPubMed Google Scholar
  8. Thomas J. Hudson
    You can also search for this author inPubMed Google Scholar
  9. Bruce E. Johnson
    You can also search for this author inPubMed Google Scholar
  10. Eric S. Lander
    You can also search for this author inPubMed Google Scholar
  11. Matthew Meyerson
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toEric S. Lander or Matthew Meyerson.

Rights and permissions

About this article

Cite this article

Lindblad-Toh, K., Tanenbaum, D., Daly, M. et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.Nat Biotechnol 18, 1001–1005 (2000). https://doi.org/10.1038/79269

Download citation

This article is cited by